Synonym
SLV-314; SLV 314; SLV314; Lensiprazine
IUPAC/Chemical Name
(R)-8-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one
InChi Key
SDAMYSWGWHXMRT-MRXNPFEDSA-N
InChi Code
InChI=1S/C24H27FN4O2/c1-16-24(30)27-21-5-2-6-22(23(21)31-16)29-12-10-28(11-13-29)9-3-4-17-15-26-20-8-7-18(25)14-19(17)20/h2,5-8,14-16,26H,3-4,9-13H2,1H3,(H,27,30)/t16-/m1/s1
SMILES Code
O=C1NC2=CC=CC(N3CCN(CCCC4=CNC5=C4C=C(F)C=C5)CC3)=C2O[C@@H]1C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
422.50
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Lange JH, Reinders JH, Tolboom JT, Glennon JC, Coolen HK, Kruse CG. Principal
component analysis differentiates the receptor binding profiles of three
antipsychotic drug candidates from current antipsychotic drugs. J Med Chem. 2007
Oct 18;50(21):5103-8. Epub 2007 Sep 19. PubMed PMID: 17880057.
2: Rauly-Lestienne I, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Cussac D.
Differential profile of typical, atypical and third generation antipsychotics at
human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and
inverse agonist properties. Naunyn Schmiedebergs Arch Pharmacol. 2007
Oct;376(1-2):93-105. Epub 2007 Sep 5. PubMed PMID: 17786406.
3: Smid P, Coolen HK, Keizer HG, van Hes R, de Moes JP, den Hartog AP, Stork B,
Plekkenpol RH, Niemann LC, Stroomer CN, Tulp MT, van Stuivenberg HH, McCreary AC,
Hesselink MB, Herremans AH, Kruse CG. Synthesis, structure-activity
relationships, and biological properties of
1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential
antipsychotics combining potent dopamine D2 receptor antagonism with potent
serotonin reuptake inhibition. J Med Chem. 2005 Nov 3;48(22):6855-69. PubMed
PMID: 16250644.